Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Pushparajah, DS"'
The current studies investigate whether synergistic or antagonistic interactions in the upregulation of CYP1 activity occur in binary mixtures of polycyclic aromatic hydrocarbons (PAHs) involving benzo[a]pyrene and five other structurally diverse PAH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::b10c97bb8113c6a087abd9ac3637d430
https://eprints.whiterose.ac.uk/118393/1/PAHS-Interactions-ET-R.pdf
https://eprints.whiterose.ac.uk/118393/1/PAHS-Interactions-ET-R.pdf
Autor:
Alsawad, Ghina1 (AUTHOR) Ghinaali9@gmail.com, Mahmoud, Ayham1 (AUTHOR), Qarain, Tareq1 (AUTHOR), Toubasi, Ahmad1 (AUTHOR), Adwan, Marwan2 (AUTHOR)
Publikováno v:
Lupus. Dec2024, Vol. 33 Issue 14, p1626-1636. 11p.
Autor:
Manning E; UCB Pharma, 8010 Arco Corporate Drive, Raleigh, NC, 27617, USA. Elizabeth.Manning@ucb.com., Herndon M; UCB Pharma, 8010 Arco Corporate Drive, Raleigh, NC, 27617, USA., Frye W; UCB Pharma, 8010 Arco Corporate Drive, Raleigh, NC, 27617, USA., Ice TS; Accelerated Enrollment Solutions, Pharmaceutical Product Development, LLC, Wake Forest, NC, USA., Thyssen N; UCB Pharma, Brussels, Belgium., Pushparajah DS; Alexion Pharmaceuticals, Hayes, UK., Yates SL; UCB Pharma, 8010 Arco Corporate Drive, Raleigh, NC, 27617, USA.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2020 Sep; Vol. 54 (5), pp. 1001-1009. Date of Electronic Publication: 2020 Jan 21.
Autor:
Pushparajah DS; Molecular Toxicology Group, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK., Ioannides C; Molecular Toxicology Group, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK. Electronic address: c.ioannides@surrey.ac.uk.
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA [Toxicol In Vitro] 2018 Aug; Vol. 50, pp. 54-61. Date of Electronic Publication: 2018 Feb 19.
Autor:
Pushparajah DS; 1 UCB Pharma, Slough, United Kingdom., Manning E; 2 UCB Pharma, Raleigh, NC, USA., Michels E; 3 UCB Pharma, Brussels, Belgium., Arnaudeau-Bégard C; 3 UCB Pharma, Brussels, Belgium.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2018 Jul; Vol. 52 (4), pp. 474-481. Date of Electronic Publication: 2017 Nov 15.
Autor:
Pushparajah DS; UCB Celltech, Slough, Berkshire, UK. Daphnee.Pushparajah@ucb.com.
Publikováno v:
The patient [Patient] 2018 Feb; Vol. 11 (1), pp. 1-8.
Autor:
Pushparajah DS; Molecular Toxicology Group, Department of Biochemistry, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom., Plant KE; Molecular Toxicology Group, Department of Biochemistry, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom., Plant NJ; Molecular Toxicology Group, Department of Biochemistry, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom., Ioannides C; Molecular Toxicology Group, Department of Biochemistry, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
Publikováno v:
Environmental toxicology [Environ Toxicol] 2017 Mar; Vol. 32 (3), pp. 764-775. Date of Electronic Publication: 2016 Apr 20.
Publikováno v:
Lupus; Jul2013, Vol. 22 Issue 8, p819-826, 8p, 2 Charts, 5 Graphs
Autor:
Petri M; a a Division of Rheumatology , Johns Hopkins University School of Medicine , Baltimore , MD , USA., Daly RP; b b Lupus Foundation of America , Washington , WA , USA., Pushparajah DS; c c UCB Pharma , Brussels , Belgium.
Publikováno v:
Journal of medical economics [J Med Econ] 2015; Vol. 18 (11), pp. 967-73. Date of Electronic Publication: 2015 Aug 14.
Autor:
AlWatban, Lemmese1,2 (AUTHOR), Alamer, Ebtihal3 (AUTHOR) E.alamer@mu.edu.sa
Publikováno v:
BMC Women's Health. 12/7/2023, Vol. 23 Issue 1, p1-9. 9p.